The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...
Zydus Lifesciences share price today, March 19: The share price of Zydus Lifesciences has risen by 1.8% in the past five trading sessions. (Image: Freepik) Zydus Lifesciences rose 3% to an intra ...
Zydus Lifesciences Limited announced on Tuesday that it has secured the final approval from the United States Food and Drug Administration (USFDA) for manufacturing and marketing apalutamide ...
Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...
The recent approval enables Zydus Lifesciences to produce and sell Apalutamide Tablets, 60 mg (a generic equivalent of Erleada) in the United States. Apalutamide is an androgen receptor inhibitor ...
Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...
Zydus Wellness, which acquired Complan in 2019, is rewriting the playbook—expanding the brand beyond kids, tapping into digital commerce, and leveraging scientific credibility to solidify its ...
Zydus Lifesciences Ltd said it has successfully concluded a United States Food and Drug Administration (USFDA) surveillance inspection at its API Unit 1 in Ankleshwar in Gujarat. Inspection ...
Zydus Lifesciences share price extended the gains on third consecutive session on March 19, rising more than 1 percent after company received final approval from USFDA for Apalutamide Tablets, 60 ...
Bank of Baroda’s mDigiNext mobile app is currently available on Android and will soon be available on iOS | Photo Credit: ANUSHREE FADNAVIS Bank of Baroda (BoB) has launched ‘mDigiNext mobile ...
The companies behind the product pulls are Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, all three of which hail from India. The drugmakers are recalling seizure treatments ...
Zydus Lifesciences Ltd share price was down by -1.77% from the previous closing price of ₹923.70. Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results